Diseases are addressed in chapters on functional annotation of lncRNAs in human disease, metabolomics characterization of human diseases, disease risk factors using SNP data and Bayesian methods, and imaging informatics for diagnostic imaging marker selection.
Translational medicine facilitates the characterization of disease processes and the generation of novel hypotheses based on direct human observation.
The further identification and characterization of disease-associated SNPs can provide information on disease risk and facilitate the development of new drugs and techniques for diagnosis.
Due to lack of more effective screening approaches, identification and functional characterization of disease-causal SNPs remains as a significant challenge.
In vivo neural molecular imaging has played an extremely important role not only in diagnosis, but also in longitudinal characterization of disease progression for Alzheimer's patients.
Such use cases span a range from the biomolecular characterization of disease states to the comprehensive phenotyping of patients to the promotion of population health.
These limitations are discussed with an indication of future developments that will accelerate the validation of data generated when completing a molecular characterization of disease pathogenesis in cattle.
Photoluminescent semiconductor nanocrystals, or quantum dots (QDs), hold promise as contrast agents for the diagnosis and characterization of disease using optical imaging.
Peraza-Echeverria, S., Dale, J. L., Harding, R. M., Smith, M. K. & Collet, C. Characterization of disease resistance gene candidates of the nucleotide binding site (NBS) type from banana and correlation of a transcriptional polymorphism with resistance to Fusarium oxysporum f.sp.sp
